COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,625 Articles (22,913 medRxiv, 8,712 bioRxiv)

Most recent first Previous |  Page 1817: Articles 18161-18170  | Next

Analysis of key factors of a SARS-CoV-2 vaccination program: A mathematical modeling approach
Martinez-Rodriguez, D., Gonzalez-Parra, G., Villanueva-Mico, R.-J.
10.1101/2021.02.19.21252095 — Posted: 2021-02-23
Phased implementation of COVID-19 vaccination: rapid assessment of policy adoption, reach and effectiveness to protect the most vulnerable in the US
Li, Y., Li, M., Rice, M., Su, Y., Yang, C.
10.1101/2021.02.19.21252118 — Posted: 2021-02-23
The Association of Opening K-12 Schools and Colleges with the Spread of COVID-19 in the United States: County-Level Panel Data Analysis
Chernozhukov, V., Kasahara, H., Schrimpf, P.
10.1101/2021.02.20.21252131 — Posted: 2021-02-23
SARS-CoV-2 disinfection in aqueous solution by UV222 from a krypton chlorine excilamp
Robinson, R. T., Mahfooz, N., Rosas-Mejia, O., Liu, Y., Hull, N. M.
10.1101/2021.02.19.21252101 — Posted: 2021-02-23
Transmission of SARS-CoV-2 Considering Shared Chairs in Outpatient Dialysis: A Real-World Case-Control Study
Thadhani, R., Willetts, J., Wang, C., Larkin, J. W., Zhang, H., Rivera Fuentes, L., Usvyat, L., Belmonte, K., Wang, Y., Kossmann, R., Hymes, J., Kotanko, P., Maddux, F. W.
10.1101/2021.02.20.21251855 — Posted: 2021-02-23 Discussion: Offsite
Health-related quality of life of adult COVID-19 patients following one-month illness experience since diagnosis: findings of a cross-sectional study in Bangladesh
Islam, M. Z., Riaz, B. K., Efa, S. S., Farjana, S., Mahmood, F.
10.1101/2021.02.19.21252073 — Posted: 2021-02-23
Controlling the first wave of the COVID-19 pandemic in Malawi: results from a panel study
Banda, J., Dube, A. N., Brumfield, S., Crampin, A. C., Reniers, G., Amoah, A. S., Helleringer, S.
10.1101/2021.02.21.21251597 — Posted: 2021-02-23
Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19
Rao, C., Robinson, T., Huster, K., Laws, R., Keating, R., Tobolowsky, F., McMichael, T., Gonzales, E., Mosites, E.
10.1101/2021.02.22.21251646 — Posted: 2021-02-23
Clinical profile and factors associated with COVID-19 in Cameroon: a prospective cohort study
Fouda Mbarga, N., Epee, E., Mbarga, M., Ouamba, J. P., Nanda, H., Kengni, A., Guekeme, J., Eyong, J., Tossoukpe, S., Noumedem Sosso, S., Ngono Ngono, E., Bonyomo, L., Tchatchoua, P., Vogue, N., Metomb, S., Ale, F., Ousman, M., Job, D., Moussi, C., Tamakloe, M., Haberer, J. E., Ndeso Atanga, S., Halle Ekane, G., Boum, Y.
10.1101/2021.02.19.21252071 — Posted: 2021-02-23
Long-term air pollution and other risk factors associated with COVID-19 at the census-tract-level in Colorado
Berg, K., Romer Present, P., Richardson, K.
10.1101/2021.02.19.21252019 — Posted: 2021-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).